KR20240006020A - 염색체 상호작용 마커 - Google Patents

염색체 상호작용 마커 Download PDF

Info

Publication number
KR20240006020A
KR20240006020A KR1020237033851A KR20237033851A KR20240006020A KR 20240006020 A KR20240006020 A KR 20240006020A KR 1020237033851 A KR1020237033851 A KR 1020237033851A KR 20237033851 A KR20237033851 A KR 20237033851A KR 20240006020 A KR20240006020 A KR 20240006020A
Authority
KR
South Korea
Prior art keywords
cancer
dna
immunotherapy
individual
homo sapiens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237033851A
Other languages
English (en)
Korean (ko)
Inventor
아룰 셀밤 라마다스
이완 헌터
알렉산드르 아쿨리체프
Original Assignee
옥스포드 바이오다이나믹스 피엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 옥스포드 바이오다이나믹스 피엘씨 filed Critical 옥스포드 바이오다이나믹스 피엘씨
Publication of KR20240006020A publication Critical patent/KR20240006020A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020237033851A 2021-03-04 2022-03-03 염색체 상호작용 마커 Pending KR20240006020A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163156659P 2021-03-04 2021-03-04
US63/156,659 2021-03-04
US202163282284P 2021-11-23 2021-11-23
US63/282,284 2021-11-23
PCT/GB2022/050561 WO2022185062A1 (en) 2021-03-04 2022-03-03 Chromosome interaction markers

Publications (1)

Publication Number Publication Date
KR20240006020A true KR20240006020A (ko) 2024-01-12

Family

ID=80735500

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237033851A Pending KR20240006020A (ko) 2021-03-04 2022-03-03 염색체 상호작용 마커

Country Status (15)

Country Link
US (1) US20240229135A9 (cg-RX-API-DMAC7.html)
EP (1) EP4301874B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024511292A (cg-RX-API-DMAC7.html)
KR (1) KR20240006020A (cg-RX-API-DMAC7.html)
AU (1) AU2022230780B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023017802A2 (cg-RX-API-DMAC7.html)
CA (1) CA3209544A1 (cg-RX-API-DMAC7.html)
ES (1) ES3029416T3 (cg-RX-API-DMAC7.html)
GB (1) GB2618727B (cg-RX-API-DMAC7.html)
HU (1) HUE071359T2 (cg-RX-API-DMAC7.html)
IL (1) IL304883A (cg-RX-API-DMAC7.html)
PL (1) PL4301874T3 (cg-RX-API-DMAC7.html)
TW (1) TW202302862A (cg-RX-API-DMAC7.html)
WO (1) WO2022185062A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202309162B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202412610D0 (en) * 2024-08-28 2024-10-09 Oxford BioDynamics PLC Screening method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111511930B (zh) * 2017-11-03 2024-11-22 牛津生物动力有限责任公司 通过染色体相互作用遗传调节免疫响应
WO2020198676A1 (en) * 2019-03-28 2020-10-01 Bristol-Myers Squibb Company Methods of treating tumor
GB2626699B (en) * 2019-05-08 2024-11-20 Oxford BioDynamics PLC Chromosome Conformation Markers of Prostate Cancer and Lymphoma
WO2021228888A1 (en) * 2020-05-12 2021-11-18 Asylia Diagnostics Biomarkers for hyperprogressive disease and therapy response after immunotherapy

Also Published As

Publication number Publication date
JP2024511292A (ja) 2024-03-13
US20240229135A9 (en) 2024-07-11
BR112023017802A2 (pt) 2023-12-12
TW202302862A (zh) 2023-01-16
AU2022230780A1 (en) 2023-10-12
EP4301874C0 (en) 2025-04-23
HUE071359T2 (hu) 2025-08-28
ES3029416T3 (en) 2025-06-24
EP4301874B1 (en) 2025-04-23
GB202313067D0 (en) 2023-10-11
WO2022185062A1 (en) 2022-09-09
AU2022230780B2 (en) 2024-05-23
ZA202309162B (en) 2025-03-26
GB2618727A (en) 2023-11-15
US20240132959A1 (en) 2024-04-25
PL4301874T3 (pl) 2025-06-23
GB2618727B (en) 2024-07-17
CA3209544A1 (en) 2022-09-09
EP4301874A1 (en) 2024-01-10
IL304883A (en) 2023-10-01

Similar Documents

Publication Publication Date Title
JP7631400B2 (ja) 遺伝子調節
JP2025032205A (ja) 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー
US20260002208A1 (en) Chromosome interactions
US20240132959A1 (en) Chromosome Interaction Markers
JP2022532108A5 (cg-RX-API-DMAC7.html)
JP2023545364A (ja) 疾患マーカー
JP2020513748A (ja) 分類法
WO2021245409A1 (en) Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma
JP2022548249A (ja) 診断用染色体マーカー
CN117795098A (zh) 染色体相互作用标志物
TW202548029A (zh) 染色體標記測試

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231004

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250228

Comment text: Request for Examination of Application